Sign in

    International Flavors & Fragrances Inc (IFF)

    You might also like

    International Flavors & Fragrances Inc. (IFF) is a leading creator and manufacturer of a diverse range of products used in consumer goods . The company operates through four main segments, offering natural-based ingredients, biotechnology-derived products, fragrance compounds, and pharmaceutical excipients . IFF's products serve various markets, including food, non-food, perfumes, household products, and industrial uses .

    1. Nourish - Offers natural-based ingredients that enhance nutritional value, texture, and functionality in food applications such as beverages, dairy, bakery, and confectionery.
    2. Health & Biosciences - Focuses on biotechnology-derived products like enzymes, probiotics, and specialty ingredients for both food and non-food applications, serving markets such as animal nutrition and grain processing.
    3. Scent - Produces fragrance compounds and ingredients used in perfumes and household products.
    4. Pharma Solutions - Provides pharmaceutical excipients and other specialty products for industrial uses.
    NamePositionExternal RolesShort Bio

    Angela Strzelecki

    Executive

    President, Pharma Solutions

    None

    President of Pharma Solutions since February 2021. Former Platform Leader for Pharma Solutions at DuPont. Over 20 years of leadership experience in the pharmaceutical industry.

    Casper Vroemen

    Executive

    EVP, Chief Research & Development Officer

    None

    Joined IFF in 2004; promoted to Chief R&D Officer in September 2023. Extensive experience in R&D leadership roles across Europe and the U.S..

    Deborah Borg

    Executive

    EVP, Chief HR, Diversity & Inclusion, and Communications Officer

    None

    Joined IFF on August 29, 2022. Former Chief HR and Communications Officer at Bunge Limited. Extensive HR leadership experience at Dow Chemical and General Motors.

    Glenn Richter

    Executive

    EVP, Chief Financial & Business Transformation Officer

    None

    CFO from September 2021 to February 2023; transitioned to Chief Financial & Business Transformation Officer in February 2023. Former CFO of TIAA.

    J. Erik Fyrwald

    Executive

    Chief Executive Officer

    Board Member at Eli Lilly and Company; Board Member of Syngenta Group

    CEO of IFF since February 6, 2024, with over four decades of experience in agriculture, nutrition, and chemicals industries. Former CEO of Syngenta and Univar Solutions.

    View Report →

    Jennifer Johnson

    Executive

    EVP, General Counsel and Corporate Secretary

    None

    General Counsel since February 2021. Former Associate General Counsel for DuPont's N&B Business. Extensive legal experience in intellectual property and corporate law.

    Michael DeVeau

    Executive

    EVP, Chief Financial Officer

    None

    CFO since January 1, 2025. Joined IFF in 2009 and held various senior finance roles, including SVP of Corporate Finance and Investor Relations.

    Ralf Finzel

    Executive

    EVP, Global Operations Officer

    None

    Joined IFF on November 1, 2022. Former VP of Integrated Supply Chain at Honeywell International. Extensive experience in operations and supply chain management.

    Simon Herriott

    Executive

    President, Health & Biosciences

    None

    President of Health & Biosciences since February 2021. Former Global Business Director at DuPont's Industrial Biosciences division.

    Vic Verma

    Executive

    EVP, Chief Information Officer

    None

    CIO since 2016, promoted to EVP in February 2021. Former VP of Global Infrastructure Operations at American Express.

    Yuvraj Arora

    Executive

    EVP & President, Nourish

    None

    Joined IFF on June 19, 2023. Former President of six U.S. categories at Kellogg North America. Over 20 years of experience in marketing and category management.

    Carol Anthony Davidson

    Board

    Director

    Board Member at TE Connectivity; Board Member at FMC Corporation

    Director since 2021. Former CFO of Tyco International. Extensive expertise in financial reporting and internal controls.

    Christina Gold

    Board

    Director

    Board Member at Safe Water Network

    Director since 2013. Former CEO of Western Union. Extensive experience in governance and corporate responsibility.

    Cynthia Jamison

    Board

    Director

    Chair of the Board at Darden Restaurants; Chair of the Board at Big Lots

    Director since January 1, 2025. Former CFO and turnaround expert. Extensive experience in financial strategy and governance.

    Dawn C. Willoughby

    Board

    Director

    Board Member at J.M. Smucker Company; Board Member at TE Connectivity

    Director since February 1, 2023. Former COO of The Clorox Company. Extensive experience in operations and governance.

    Gary Hu

    Board

    Director

    Board Member at Dana Incorporated; Board Member at Bausch & Lomb Corporation

    Director since February 1, 2023. Portfolio Manager at Icahn Capital LP. Extensive experience in M&A and financial strategy.

    John F. Ferraro

    Board

    Director

    Board Member at Advance Auto Parts, Inc.; Board Member at ManpowerGroup Inc.

    Director since 2015. Former Global COO of Ernst & Young. Extensive experience in auditing, accounting, and global business operations.

    Kathryn J. Boor

    Board

    Director

    Dean of the Graduate School at Cornell University; Board Member at Seneca Foods Corporation; Board Member at Sarepta Therapeutics, Inc.

    Director since 2021. Expert in food and beverage science, molecular biology, and food safety. Former Dean of the College of Agriculture and Life Sciences at Cornell University.

    Kevin O’Byrne

    Board

    Director

    Board Member at Centrica plc; Board Member at J Sainsbury plc

    Director since March 10, 2023. Former CFO of J Sainsbury plc. Extensive experience in finance and retail leadership.

    Margarita Paláu-Hernández

    Board

    Director

    Director at Conduent Incorporated; Director at Apartment Income REIT Corp.

    Director since June 3, 2024. CEO of Hernández Ventures. Former U.S. Representative to the UN General Assembly with the rank of Ambassador.

    Mark J. Costa

    Board

    Director

    CEO and Chair of Eastman Chemical Company

    Director since 2023. CEO of Eastman Chemical Company since 2014. Extensive leadership experience in the chemical industry.

    Roger W. Ferguson, Jr.

    Board

    Chair of the Board of Directors

    Board Member at Alphabet Inc.; Board Member at Corning Incorporated

    Chair of IFF's Board since April 12, 2023. Former President and CEO of TIAA. Extensive experience in finance and governance.

    Vincent Intrieri

    Board

    Director

    Director at Transocean Ltd.; Director at Hertz Global Holdings; Chairman of the Board at SandRidge Energy Inc.

    Director since January 1, 2025. Founder of VDA Capital Management LLC. Extensive experience in investment and corporate governance.

    1. With the increased reinvestment needs in R&D and innovation, including the additional $20 million planned in Q3 and Q4 , how do you plan to balance this with your goal of continuously improving margins and ROIC, and can you provide more specifics on achieving both objectives?

    2. Given your net debt of $9.1 billion and a net debt to EBITDA ratio of 3.9x , what specific steps are you taking to strengthen your capital structure and reduce leverage, especially considering the upcoming divestiture of the Pharma Solutions business?

    3. With your updated full-year guidance expecting net sales of $11.3 billion to $11.4 billion and adjusted operating EBITDA at the high end of $2.1 billion to $2.17 billion , can you elaborate on the key risks that could prevent you from achieving these targets, particularly in light of potential macroeconomic headwinds?

    4. You mentioned a flat price/cost dynamic expected for next year ; can you provide more clarity on how you plan to manage potential increases in raw material costs and tariffs, and what impact these could have on your margins?

    5. Regarding the Functional Ingredients business turnaround and the ongoing restructuring of your global supply chain footprint , what key challenges do you foresee in achieving the targeted EBITDA margins of 15% plus, and how confident are you in meeting those targets within the planned timeframe?

    YearAmount Due (in millions)Debt TypeInterest Rate (%)% of Total Debt
    2024$468 2026 Term Loan Facility (current portion)5.21 5.1% = (468 / 9,099) * 100
    2025$1,000 2025 Notes1.22 11.0% = (1,000 / 9,099) * 100
    2026$892 2026 Euro Notes1.93 9.8% = (892 / 9,099) * 100
    2027$1,210 2027 Notes1.56 13.3% = (1,210 / 9,099) * 100
    2028$398 2028 Notes4.57 4.4% = (398 / 9,099) * 100
    2030$1,508 2030 Notes2.21 16.6% = (1,508 / 9,099) * 100
    2040$772 2040 Notes3.04 8.5% = (772 / 9,099) * 100
    2047$494 2047 Notes4.44 5.4% = (494 / 9,099) * 100
    2048$787 2048 Notes5.12 8.6% = (787 / 9,099) * 100
    2050$1,568 2050 Notes3.21 17.2% = (1,568 / 9,099) * 100

    Competitors mentioned in the company's latest 10K filing.

    CompanyDescription

    Givaudan

    One of the large global companies competing in the broader market that includes functional foods, food additives, natural ingredients, nutritional ingredients, supplements, and active cosmetic ingredients.

    DSM-Firmenich

    A major competitor in the global market for ingredients and compounds used in consumer products, including functional foods and food additives.

    Symrise

    Identified as a key competitor in the highly competitive market for products such as seasonings, probiotics, and fortified products.

    Kerry

    Competes in the market for functional food ingredients and other consumer product-related compounds.

    Listed among the large global companies competing in the market for natural and nutritional ingredients.

    Novonesis

    Included as one of the main competitors in the market for food-related commodities and active cosmetic ingredients.

    NameStart DateEnd DateReason for Change
    PricewaterhouseCoopers LLP1957 PresentCurrent auditor

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    Health Wright Products, Inc.

    2022

    Completed on April 1, 2022, this deal was valued at approximately $157 million (including cash and contingent consideration) and was aimed at strengthening capabilities in formulation and finished format sectors within the Health & Biosciences business, with the purchase agreement executed on February 16, 2022 and key acquired assets including significant intangible assets and goodwill.

    Recent press releases and 8-K filings for IFF.

    Intl Flavors & Fragrances Inc Announces Executive Departure
    IFF
    Management Change
    • International Flavors & Fragrances Inc announced on March 13, 2025 that Jennifer Johnson, the Executive Vice President, General Counsel, and Corporate Secretary, has resigned effective July 1, 2025.
    • The resignation qualifies under the company’s executive severance policy, ensuring a managed transition process following her departure.
    Mar 13, 2025, 12:00 AM